At a glance
During this COCA Call, Centers for Disease Control and Prevention experts will review recommendations for mpox testing, vaccination, treatment, and prevention. With new mpox cases occurring in some people who are vaccinated, it is important that clinicians quickly identify cases to limit a possible mpox resurgence this summer in the United States.
Webinar
The fully captioned video and edited transcript will be posted within the next few days. Please note that a correction was made to the JYNNEOS Vaccine Efficacy table slide post-call. VE for 2 doses in the New York state case-control study was corrected from 76% to 89%. We have updated the slides but the recording still contains the outdated number.
Overview
During this COCA Call, Centers for Disease Control and Prevention experts will review recommendations for mpox testing, vaccination, treatment, and prevention. With new mpox cases occurring in some people who are vaccinated, it is important that clinicians quickly identify cases to limit a possible mpox resurgence this summer in the United States.
Presenters
John T. Brooks, MD
Chief Medical Officer
Division of HIV Prevention
National Center for HIV, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
Chris Braden, MD
Incident Manager
2022 Multinational Mpox Response
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Call Objectives
At the conclusion of the session, the participant will be able to accomplish the following:
- Cite background information on the topic covered during the presentation.
- Discuss CDC's role in the topic covered during the presentation.
- Describe the topic's implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.
Additional Resources
- Clinical Recognition
- Clinical Quick Reference
- Mpox Vaccine Information for Healthcare Professionals
- Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines during the 2022 U.S. Mpox Outbreak
- Treatment Information for Healthcare Professionals
- Mpox Infections after Vaccination
- MMWR: The CDC Domestic Mpox Response — United States, 2022–2023
- MMWR: Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection — New York, 2022
- MMWR: Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023
- NEJM: Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States
Target Audience
- Physicians
- Nurses
- Pharmacists
- Veterinarians
- Physician Assistants
- Health Educators
- Other Clinicians
Additional Information
- Contact Information: coca@cdc.gov
- Support/Funding: Centers for Disease Control and Prevention, Emergency Risk Communication Branch
- Method of Participation: You may participate in the educational activity by viewing the program information above.